Abstract:Abstract <sec> Objectives To test the survival and release of probiotics (Lactobacillus rhamnosus GG and Bifidobacterium animalis subsp. lactis BB-12), a prebiotic (bacteriophage blend), and a postbiotic (tributyrin) in a capsule-within-capsule design during passage through the gastrointestinal tract under fed and fasted conditions. </sec> <sec> Methods Using an adapted Simulator of the Human Intestinal Microbial Ecosystem (SHIME®) model, physiological conditions of the stomach and small intestine, including pH profiles, temperature, incubation time, and addition of bile liquid and digestive enzymes, were simulated within the same reactor over time. The capsule contents included an inner capsule, containing probiotics and prebiotic phages, and an outer capsule, containing the postbiotic, with different delivery and release characteristics. Probiotic survival was assessed via plate counts and PMA-qPCR, release of phages was assessed via phage titer assay, and tributyrin release was assessed via gas chromatography. All experiments were performed in triplicate to account for biological variability. </sec> <sec> Results Under fasted conditions, the majority of the probiotics bypassed the stomach and small intestine in a viable form, of which more than 11 billion CFU were culturable. There were no significant differences between fasted and fed states. Similarly, the majority of the prebiotic phages survived transit through the stomach and small intestine. Tributyrin was mostly released in the small intestine. </sec> <sec> Conclusions The capsule design ensured probiotics and prebiotic phages survived the harsh conditions of the upper gastrointestinal tract for delivery to the colon. The release of tributyrin within the small intestine supports its breakdown by pancreatic enzymes to produce short chain fatty acid butyrate. The findings of this study suggest a novel, colon-targeted probiotic delivery system explained by specific capsule and content characteristics. </sec> <sec> Funding Sources The study was conducted by an independent lab, ProDigest, and funded and sponsored by Ritual (Natals, Inc.). Compound Solutions, Inc. also financially supported the study. </sec>

3D Printed pH-responsive Colonic Capsules for the Delivery of Live Aqueous Bacterial Suspensions

Colonic Delivery of Aqueous Suspensions Using 3D Printed Capsules

Carboxymethyl Konjac Glucomannan-Chitosan Complex Nanogels Stabilized Emulsions Incorporated into Alginate As Microcapsule Matrix for Intestinal-Targeted Delivery of Probiotics: in Vivo and in Vitro Studies.

Targeted delivery of probiotics to enhance gastrointestinal stability and intestinal colonisation

Targeted Delivery of Narrow-Spectrum Protein Antibiotics to the Lower Gastrointestinal Tract in a Murine Model of Escherichia coli Colonization

Efficient Protection of Probiotics for Delivery to the Intestinal tract by Cellulose Sulphate Encapsulation

A Colon‐Targeted Oral Probiotics Delivery System Using an Enzyme‐Triggered Fuse‐Like Microcapsule

Efficient protection of microorganisms for delivery to the intestinal tract by cellulose sulphate encapsulation

Development of enteric polymer-based microspheres by spray-drying for colonic delivery of Lactobacillus rhamnosus GG

Bifidobacteria Encapsulation and Viability of Probiotic Culture during Oral Delivery in a Milk Drink Matrix

Optimization of a gelatin/carboxymethylcellulose-based probiotic microcapsule and its application in preventing dextran sodium sulfate-induced colitis in mice.

Survival and Release Behavior of a Novel Pre-, Pro-, and Postbiotic Capsule in an In Vitro SHIME Model

Survival of Probiotic Bacterial Cells in the Upper Gastrointestinal Tract and the Effect of the Surviving Population on the Colonic Microbial Community Activity and Composition

Development of a novel probiotic delivery system based on microencapsulation with protectants

Encapsulation of bifidobacterium in alginate microgels improves viability and targeted gut release

Sustained dual delivery of metronidazole and viable Lactobacillus crispatus from 3D-printed silicone shells

Survival of probiotic bacteria nanoencapsulated within biopolymers in a simulated gastrointestinal model

Multishell Colloidosome Platform with Sequential Gastrointestinal Resistance for On-Demand Probiotic Delivery.

Development of a shelf-stable, gel-based delivery system for probiotics by encapsulation, 3D printing, and freeze-drying

The Effect of Encapsulating a Prebiotic-Based Biopolymer Delivery System for Enhanced Probiotic Survival